SEARCH

SEARCH BY CITATION

References

  • 1
    DeSantis C, Howlader N, Cronin KA, Jemal A. Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev 2011;20(5):733739.
  • 2
    Daubisse-Marliac L, Delafosse P, Boitard JB, Poncet F, Grosclaude P, Colonna M. Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Ann Oncol 2011;22(2):329334.
  • 3
    Han YY, Talbott E, Donovan M. Time trends and racial differences in female breast cancer incidence in Pennsylvania, 1985–2004. J Womens Health (Larchmt) Epub 2011 Feb 25. DOI: 10.1089/jwh.2010.2082.
  • 4
    Mistry M, Parkin DM, Ahmad AS, Sasieni P. Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer 2011;105(11):17951803.
  • 5
    Available from: http://www.aihw.gov.au/publication-detail/?id=6442472459. Cancer in Australia 2010: an overview, 2010. [cited 2011 25 October]
  • 6
    Available from: http://seer.cancer.gov/csr/1975_2008/index.html. SEER Cancer Statistics Review of the United States, 2011. [cited 2011 25 October]
  • 7
    Available from: http://info.cancerresearchuk.org/cancerstats/reports/. Survival statistics for the most common cancers, 2011. [cited 2011 25 October]
  • 8
    Epping-Jordan JE, Compas BE, Osowiecki DM et al. Psychological adjustment in breast cancer: processes of emotional distress. Health Psychol 1999;18(4):315326.
  • 9
    Montgomery M, McCrone SH. Psychological distress associated with the diagnostic phase for suspected breast cancer: systematic review. J Adv Nurs 2010;66(11):23722390.
  • 10
    Vickberg SM, Bovbjerg DH, DuHamel KN, Currie V, Redd WH. Intrusive thoughts and psychological distress among breast cancer survivors: global meaning as a possible protective factor. Behav Med 2000;25(4):152160.
  • 11
    Hegel MT, Moore CP, Collins ED, et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 2006;107(12):29242931.
  • 12
    Chen X, Zheng Y, Zheng W et al. Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol 2009;48(8):11281136.
  • 13
    Popoola AO, Adewuya AO. Prevalence and correlates of depressive disorders in outpatients with breast cancer in Lagos, Nigeria. Psycho-Oncology Epub 2011 Apr 3. DOI: 10.1002/pon.1968.
  • 14
    Qiu J, Yang M, Chen W et al. Prevalence and correlates of major depressive disorder in breast cancer survivors in Shanghai, China. Psycho-Oncology Epub 2011 Oct 9. DOI: 10.1002/pon.2075.
  • 15
    Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thai 2007;90(10):21642174.
  • 16
    Reyes-Gibby CC, Anderson KO, Morrow PK, Shete S, Hassan S. Depressive symptoms and health-related quality of life in breast cancer survivors. J Womens Health (Larchmt) Epub 2011 Nov 7. DOI: 10.1089/jwh.2011.2852.
  • 17
    Ng CG, Boks MP, Zainal NZ, de Wit NJ. The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord 2011;131(1–3):17.
  • 18
    Available from: www.nccn.org/professionals/physician_gls/f_guidelines.asp. NCCN Clinical Practice Guidelines in Oncology, 2011. [cited 2011 25 October]
  • 19
    Available from: http://www.mentalhealth.org.uk/publications. Mental Health Foundation—Be Mindful Report, United Kingdom, 2010.
  • 20
    Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry 1982;4:3347.
  • 21
    Kabat-Zinn J, Wheeler E, Light T et al. Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom Med 1998;60(5):625632.
  • 22
    Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res 2004;57(1):3543.
  • 23
    Branstrom R, Kvillemo P, Moskowitz JT. A randomized study of the effects of mindfulness training on psychological well-being and symptoms of stress in patients treated for cancer at 6-month follow-up. Int J Behav Med Epub 2011 Sept 20. DOI: 10.1007/s12529-011-9192-3.
  • 24
    Lerman R, Jarski R, Rea H, Gellish R, Vicini F. Improving symptoms and quality of life of female cancer survivors: a randomized controlled study. Ann Surg Oncol Epub 2011 Sep 13. DOI: 10.1245/s10434-011-2051-2.
  • 25
    Birnie K, Garland SN, Carlson LE. Psychological benefits for cancer patients and their partners participating in mindfulness-based stress reduction (MBSR). Psycho-Oncology 2010;19(9):10041009.
  • 26
    Kieviet-Stijnen A, Visser A, Garssen B, Hudig W. Mindfulness-based stress reduction training for oncology patients: patients' appraisal and changes in well-being. Patient Educ Couns 2008;72(3):436442.
  • 27
    Speca M, Carlson LE, Goodey E, Angen M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med 2000;62(5):613622.
  • 28
    Pradhan EK, Baumgarten M, Langenberg P et al. Effect of mindfulness-based stress reduction in rheumatoid arthritis patients. Arthritis Rheum 2007;57(7):11341142.
  • 29
    Sephton SE, Salmon P, Weissbecker I et al. Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial. Arthritis Rheum 2007;57(1):7785.
  • 30
    van Son J, Nyklicek I, Pop VJ, Pouwer F. Testing the effectiveness of a mindfulness-based intervention to reduce emotional distress in outpatients with diabetes (DiaMind): design of a randomized controlled trial. BMC Public Health 2011;11:131.
  • 31
    Kreitzer MJ, Gross CR, Ye X, Russas V, Treesak C. Longitudinal impact of mindfulness meditation on illness burden in solid-organ transplant recipients. Prog Transplant 2005;15(2):166172.
  • 32
    Gross CR, Kreitzer MJ, Thomas W et al. Mindfulness-based stress reduction for solid organ transplant recipients: a randomized controlled trial. Altern Ther Health Med 2010;16(5):3038.
  • 33
    Goldin PR, Gross JJ. Effects of mindfulness-based stress reduction (MBSR) on emotion regulation in social anxiety disorder. Emotion 2010;10(1):8391.
  • 34
    Vollestad J, Sivertsen B, Nielsen GH. Mindfulness-based stress reduction for patients with anxiety disorders: evaluation in a randomized controlled trial. Behav Res Ther 2011;49(4):281288.
  • 35
    Cohen-Katz J, Wiley SD, Capuano T, Baker DM, Shapiro S. The effects of mindfulness-based stress reduction on nurse stress and burnout: a quantitative and qualitative study. Holist Nurs Pract 2004;18(6):302308.
  • 36
    Martin-Asuero A, Garcia-Banda G. The mindfulness-based stress reduction program (MBSR) reduces stress-related psychological distress in healthcare professionals. Span J Psychol 2010;13(2):897905.
  • 37
    Pipe TB, Bortz JJ, Dueck A, Pendergast D, Buchda V, Summers J. Nurse leader mindfulness meditation program for stress management: a randomized controlled trial. J Nurs Adm 2009;39(3):130137.
  • 38
    Smith JE, Richardson J, Hoffman C, Pilkington K. Mindfulness-based stress reduction as supportive therapy in cancer care: systematic review. J Adv Nurs 2005;52(3):315327.
  • 39
    Ledesma D, Kumano H. Mindfulness-based stress reduction and cancer: a meta-analysis. Psycho-Oncology 2009;18(6):571579.
  • 40
    Shennan C, Payne S, Fenlon D. What is the evidence for the use of mindfulness-based interventions in cancer care? A review. Psycho-Oncology 2011;20(7):681697.
  • 41
    Matchim Y, Armer JM, Stewart BR. Mindfulness-based stress reduction among breast cancer survivors: a literature review and discussion. Oncol Nurs Forum 2011;38(2):E61E71.
  • 42
    Grigoriadis S, Robinson GE. Gender issues in depression. Ann Clin Psychiatry 2007;19(4):247255.
  • 43
    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
  • 44
    Cohen J (ed.). Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum: New Jersey, 1988.
  • 45
    Petitti DB (ed.). Meta-Analysis, Decision Analysis, and Cost-effectiveness Analysis: Methods for Quantitative Synthesis in Medicine. Oxford University Press: New York, 2000.
  • 46
    Leandro G (ed.). Meta-Analysis in Medical Research: the Handbook for the Understanding and Practice of Meta-analysis. BMJ Publishing Group Limited: Oxford, UK, 2005.
  • 47
    Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56(2):455463.
  • 48
    Dobkin PL. Mindfulness-based stress reduction: what processes are at work? Complement Ther Clin Pract 2008;14(1):816.
  • 49
    Matousek RH, Pruessner JC, Dobkin PL. Changes in the cortisol awakening response (CAR) following participation in mindfulness-based stress reduction in women who completed treatment for breast cancer. Complement Ther Clin Pract 2011;17(2):6570.
  • 50
    Matousek RH, Dobkin PL. Weathering storms: a cohort study of how participation in a mindfulness-based stress reduction program benefits women after breast cancer treatment. Curr Oncol 2010;17(4):6270.
  • 51
    Lengacher CA, Johnson-Mallard V, Post-White J et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psycho-Oncology 2009;18(12):12611272.
  • 52
    Lengacher CA, Johnson-Mallard V, Barta M et al. Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs 2011;29(2):107117.
  • 53
    Henderson VP, Clemow L, Massion AO, Hurley TG, Druker S, Hebert JR. The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial. Breast Cancer Res Treat Epub 2011 Sep 8. DOI: 10.1007/s10549-011-1738-1.
  • 54
    Matchim Y, Armer JM, Stewart BR. Effects of mindfulness-based stress reduction (MBSR) on health among breast cancer survivors. West J Nurs Res Epub 2010 Oct 18. DOI: 10.1177/0193945910385363.
  • 55
    Tacon A, Caldera Y, Ronaghan C. Mindfulness-based stress reduction in women with breast cancer. Fam Syst Health 2004;22(2):193203.
  • 56
    Tacon A. Mindfulness effects on symptoms of distress in women with cancer. J Cancer Pain Symptom Palliation 2006;2(2):1722.
  • 57
    Bohlmeijer E, Prenger R, Taal E, Cuijpers P. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J Psychosom Res 2010;68(6):539544.
  • 58
    Monti DA, Peterson C, Kunkel EJ et al. A randomized, controlled trial of mindfulness-based art therapy (MBAT) for women with cancer. Psycho-Oncology 2006;15(5):363373.
  • 59
    Spasojevic J, Alloy LB. Rumination as a common mechanism relating depressive risk factors to depression. Emotion 2001;1:2537.
  • 60
    Michalak J, Holz A, Teismann T. Rumination as a predictor of relapse in mindfulness-based cognitive therapy for depression. Psychol Psychother Epub 2010 Aug 10. DOI: 10.1348/147608310X520166.
  • 61
    Deyo M, Wilson KA, Ong J, Koopman C. Mindfulness and rumination: does mindfulness training lead to reductions in the ruminative thinking associated with depression? Explore (NY) 2009;5(5):265271.
  • 62
    Campbell TS, Labelle LE, Bacon SL, Faris P, Carlson LE. Impact of mindfulness-based stress reduction (MBSR) on attention, rumination and resting blood pressure in women with cancer: a waitlist-controlled study. J Behav Med Epub 2011 Jun 12. DOI: 10.1007/s10865-011-9357-1.
  • 63
    Abercrombie PD, Zamora A, Korn AP. Lessons learned: providing a mindfulness-based stress reduction program for low-income multiethnic women with abnormal pap smears. Holist Nurs Pract 2007;21(1):2634.
  • 64
    Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW. Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial. J Clin Oncol 2012;30(12):13351342.